Last Price
14.22
Today's Change
+0.09 (0.63%)
Day's Change
13.83 - 14.28
Trading Volume
3,978,492
Exchange: New York Stock Exchange New York Stock Exchange
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Jeffrey N. Simmons Mr. Jeffrey N. Simmons
Full Time Employees: 9,300 9,300
IPO Date: 2018-09-20 2018-09-20
CIK: 0001739104 0001739104
ISIN: US28414H1032 US28414H1032
CUSIP: 28414H103 28414H103
Beta: 1.42 1.42
Last Dividend: 0.00 0.00
Dcf Diff: 22.16 22.16
Dcf: -8.22 -8.22
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.